Mary J. Fidler
Rush University Medical Center
Chicago
Illinois 60612
USA
Name/email consistency: high
- The potential predictive value of cyclooxygenase-2 expression and increased risk of gastrointestinal hemorrhage in advanced non-small cell lung cancer patients treated with erlotinib and celecoxib. Fidler, M.J., Argiris, A., Patel, J.D., Johnson, D.H., Sandler, A., Villaflor, V.M., Coon, J., Buckingham, L., Kaiser, K., Basu, S., Bonomi, P. Clin. Cancer Res. (2008)